370 related articles for article (PubMed ID: 36035256)
1. All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer's disease.
St-Pierre MK; VanderZwaag J; Loewen S; Tremblay MÈ
Front Cell Neurosci; 2022; 16():932572. PubMed ID: 36035256
[TBL] [Abstract][Full Text] [Related]
2. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Astrocyte Reaction in Alzheimer's Disease.
Perez-Nievas BG; Serrano-Pozo A
Front Aging Neurosci; 2018; 10():114. PubMed ID: 29922147
[TBL] [Abstract][Full Text] [Related]
4. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease.
Sobue A; Komine O; Yamanaka K
Inflamm Regen; 2023 May; 43(1):26. PubMed ID: 37165437
[TBL] [Abstract][Full Text] [Related]
6. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction.
Bandyopadhyay S
Front Aging Neurosci; 2021; 13():653334. PubMed ID: 34211387
[TBL] [Abstract][Full Text] [Related]
7. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.
Lau JKY; Tian M; Shen Y; Lau SF; Fu WY; Fu AKY; Ip NY
Sci Rep; 2021 Feb; 11(1):4359. PubMed ID: 33623128
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
10. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease.
Sanchez-Mico MV; Jimenez S; Gomez-Arboledas A; Muñoz-Castro C; Romero-Molina C; Navarro V; Sanchez-Mejias E; Nuñez-Diaz C; Sanchez-Varo R; Galea E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Glia; 2021 Apr; 69(4):997-1011. PubMed ID: 33283891
[TBL] [Abstract][Full Text] [Related]
12. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
13. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.
Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T
J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027
[TBL] [Abstract][Full Text] [Related]
14. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
[TBL] [Abstract][Full Text] [Related]
15. The Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer's Disease.
Ziegler-Waldkirch S; Meyer-Luehmann M
Front Cell Neurosci; 2018; 12():473. PubMed ID: 30618627
[TBL] [Abstract][Full Text] [Related]
16. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
Uddin MS; Lim LW
Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810
[TBL] [Abstract][Full Text] [Related]
17. Dystrophic microglia in late-onset Alzheimer's disease.
Streit WJ; Khoshbouei H; Bechmann I
Glia; 2020 Apr; 68(4):845-854. PubMed ID: 31922322
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
[TBL] [Abstract][Full Text] [Related]
19. Microglia in Alzheimer's Disease.
Süß P; Schlachetzki JCM
Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
[TBL] [Abstract][Full Text] [Related]
20. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
Ji B; Maeda J; Sawada M; Ono M; Okauchi T; Inaji M; Zhang MR; Suzuki K; Ando K; Staufenbiel M; Trojanowski JQ; Lee VM; Higuchi M; Suhara T
J Neurosci; 2008 Nov; 28(47):12255-67. PubMed ID: 19020019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
